Susquehanna International Group
DSGN icon

Susquehanna International Group’s Design Therapeutics DSGN Stock Holding History

Susquehanna International Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61,852
Closed -$580K – 13359
2025
Q4 		$580K Buy
61,852
+47,829
+341% +$375K ﹤0.01% 8445
2025
Q3 		$106K Sell
14,023
-24,147
-63% -$121K ﹤0.01% 11539
2025
Q2 		$129K Sell
38,170
-5,053
-12% -$18.9K ﹤0.01% 11617
2025
Q1 		$167K Buy
43,223
+5,911
+16% +$28.2K ﹤0.01% 11121
2024
Q4 		$230K Buy
+37,312
New +$216K ﹤0.01% 10403
2024
Q3 		– Sell
-21,726
Closed -$102K – 12190
2024
Q2 		$72.8K Buy
21,726
+10,494
+93% +$40.9K ﹤0.01% 11224
2024
Q1 		$45.3K Sell
11,232
-9,664
-46% -$25.8K ﹤0.01% 11590
2023
Q4 		$55.4K Sell
20,896
-1,641
-7% -$3.76K ﹤0.01% 11676
2023
Q3 		$53.2K Sell
22,537
-34,257
-60% -$160K ﹤0.01% 11274
2023
Q2 		$358K Sell
56,794
-247,275
-81% -$1.51M ﹤0.01% 9079
2023
Q1 		$1.75M Buy
304,069
+279,613
+1,143% +$2.09M ﹤0.01% 5432
2022
Q4 		$251K Buy
24,456
+6,140
+34% +$83.2K ﹤0.01% 9539
2022
Q3 		$306K Sell
18,316
-5,588
-23% -$111K ﹤0.01% 9743
2022
Q2 		$335K Buy
+23,904
New +$323K ﹤0.01% 9268

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's DSGN Position: Q1 2026 in Review

Susquehanna International Group sold out of Design Therapeutics (DSGN) in Q1 2026, closing a stake of 61,852 shares — an estimated $580K sold.

Susquehanna International Group first reported a position in DSGN in Q2 2022 and held it in 14 quarters. The position peaked at $1.75M in Q1 2023. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Susquehanna International Group reported no remaining Design Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 61,852 Design Therapeutics shares in Q1 2026, an estimated $580K.
  • Susquehanna International Group first reported a position in Design Therapeutics in Q2 2022 and held it in 14 quarters.
  • Susquehanna International Group's Design Therapeutics position peaked at $1.75M in Q1 2023.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.